FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         	UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  	OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5	
                      	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	                      	

1. Name and Address of Reporting Person *

Colella Giovanni M.	2. Issuer Name and Ticker or Trading Symbol

CASTLIGHT HEALTH, INC. [ CSLT ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      __ X __ 10% Owner
_____ Officer (give title below)      __ X __ Other (specify below)
Executive Chairman	
(Last)          (First)          (Middle)

C/O CASTLIGHT HEALTH, INC., 150 SPEAR ST., SUITE 400	3. Date of Earliest Transaction (MM/DD/YYYY)

8/15/2017		
(Street)

SAN FRANCISCO, CA 94105
(City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)

 	6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person	

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned	
1.Title of Security
(Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code
(Instr. 8)	4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)	5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)	
			Code	V	Amount	(A) or (D)	Price				
Class B Common Stock  	8/15/2017  	 	M (1)	  	9187  	A	$0  	88093  	D  	 	
Class B Common Stock  	8/16/2017  	 	S	  	3662   (2) (3)	D	$3.9027   (4)	84431  	D  	 	
Class B Common Stock  	8/16/2017  	 	J (5)	  V	5525  	D	$0  	78906  	D  	 	
Class B Common Stock  	8/16/2017  	 	J (5)	  V	5525  	A	$0  	27745  	I  	By living trust   (6)	
Class B Common Stock  	8/16/2017  	 	C	  	26400  	A	$0  	54145  	I  	By living trust   (6)	
Class B Common Stock  	8/16/2017  	 	S	  	26400   (2)	D	$3.911   (7)	27745  	I  	By living trust   (6)	

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)	
1. Title of Derivate Security
(Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code
(Instr. 8)	5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)	6. Date Exercisable and Expiration Date	7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)	8. Price of Derivative Security
(Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)	
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares					
Restricted Stock Units  	$0   (8)	8/15/2017  	 	M   (1)	  	  	9187   	  (9)	  (9)	Class B Common Stock  	9187  	$0  	64313  	D  	 	
Class A Common Stock  	$0   (10) (11)	8/16/2017  	 	C  	  	  	26400   	  (10) (11)	  (10) (11)	Class B Common Stock  	26400  	$0  	4610591  	I  	By living trust   (6)	
Class A Common Stock  	$0   (10) (11)	 	 	   	  	  	  	  (10) (11)	  (10) (11)	Class B Common Stock  	509638  	 	509638  	I  	By grantor retained annuity trust 1   (12)	
Class A Common Stock  	$0   (10) (11)	 	 	   	  	  	  	  (10) (11)	  (10) (11)	Class B Common Stock  	160443  	 	160443  	I  	By grantor retained annuity trust 2   (12)	
Class A Common Stock  	$0   (10) (11)	 	 	   	  	  	  	  (10) (11)	  (10) (11)	Class B Common Stock  	509638  	 	509638  	I  	By grantor retained annuity trust 3   (13)	
Class A Common Stock  	$0   (10) (11)	 	 	   	  	  	  	  (10) (11)	  (10) (11)	Class B Common Stock  	106443  	 	106443  	I  	By grantor retained annuity trust 4   (13)	

Explanation of Responses:	
(1) 	Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on June 17, 2015, the grant of which was previously reported by the Reporting Person on a Form 4.	
(2) 	Represents the aggregate of sales effected on the same day at different prices.	
(3) 	All of these shares were sold to cover taxes and fees due upon the release and settlement of the RSUs.	
(4) 	Represents the weighted average sales price per share. The shares sold at prices ranging from $3.85 to $3.95 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.	
(5) 	Re-registration of shares in the name of the Reporting Person's living trust, effecting only a change in the form of beneficial ownership.	
(6) 	Reporting Person serves as a co-trustee.	
(7) 	Represents the weighted average sales price per share. The shares sold at prices ranging from $3.85 to $4.05 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.	
(8) 	Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration.	
(9) 	The RSUs vest over 4 years as follows: 25% of the RSUs vested on May 15, 2016 and the remainder will vest on each quarterly anniversary thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting.	
(10) 	Each share of Class A Common Stock is convertible, at any time at the option of the holder, into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, that occurs after the closing of the IPO to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class A Common Stock have no expiration date.	
(11) 	Each share of the Issuer's Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the earliest to occur of the following: (a) the first date on which the number of shares of Class A Common Stock then outstanding is less than 15,340,384 shares, (b) March 19, 2024, or (c) a time and date approved in writing by holders of at least a majority of the then-outstanding shares of Class A Common Stock. The shares of Class A Common Stock and Class B Common Stock have no expiration date.	
(12) 	Reporting Person serves as trustee and sole beneficiary.	
(13) 	Reporting Person's spouse serves as trustee and sole beneficiary.	

Reporting Owners	
Reporting Owner Name / Address	Relationships	
	Director	10% Owner	Officer	Other	
Colella Giovanni M.
C/O CASTLIGHT HEALTH, INC.
150 SPEAR ST., SUITE 400
SAN FRANCISCO, CA 94105	X	X		Executive Chairman	

Signatures		
/s/ Jennifer Chaloemtiarana, by power of attorney		8/17/2017	
** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.	
*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).	
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).	
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.	
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.